218 related articles for article (PubMed ID: 36782326)
1. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
Patel AS; Miller E; Regis SM; Hunninghake GM; Price LL; Gawlik M; McKee AB; Rieger-Christ KM; Pinto-Plata V; Liesching TN; Wald C; Hashim J; McKee BJ; Gazourian L
Respir Res; 2023 Feb; 24(1):49. PubMed ID: 36782326
[TBL] [Abstract][Full Text] [Related]
2. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
3. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
Kawano-Dourado L; Doyle TJ; Bonfiglioli K; Sawamura MVY; Nakagawa RH; Arimura FE; Lee HJ; Rangel DAS; Bueno C; Carvalho CRR; Sabbag ML; Molina C; Rosas IO; Kairalla RA
Chest; 2020 Oct; 158(4):1546-1554. PubMed ID: 32428513
[TBL] [Abstract][Full Text] [Related]
4. Increased respiratory morbidity in individuals with interstitial lung abnormalities.
Hoyer N; Thomsen LH; Wille MMW; Wilcke T; Dirksen A; Pedersen JH; Saghir Z; Ashraf H; Shaker SB
BMC Pulm Med; 2020 Mar; 20(1):67. PubMed ID: 32188453
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.
Mackintosh JA; Marshall HM; Slaughter R; Reddy T; Yang IA; Bowman RV; Fong KM
Intern Med J; 2019 Jul; 49(7):843-849. PubMed ID: 30350396
[TBL] [Abstract][Full Text] [Related]
6. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
Salisbury ML; Hewlett JC; Ding G; Markin CR; Douglas K; Mason W; Guttentag A; Phillips JA; Cogan JD; Reiss S; Mitchell DB; Wu P; Young LR; Lancaster LH; Loyd JE; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
Am J Respir Crit Care Med; 2020 May; 201(10):1230-1239. PubMed ID: 32011901
[No Abstract] [Full Text] [Related]
7. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.
Grant-Orser A; Min B; Elmrayed S; Podolanczuk AJ; Johannson KA
Am J Respir Crit Care Med; 2023 Sep; 208(6):695-708. PubMed ID: 37534937
[No Abstract] [Full Text] [Related]
9. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy.
García Mullor MM; Arenas-Jiménez JJ; Ureña Vacas A; Gayá García-Manso I; Pérez Pérez JL; Serra Serra N; García Sevila R
Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S10-S23. PubMed ID: 38642956
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
Lee JE; Chae KJ; Suh YJ; Jeong WG; Lee T; Kim YH; Jin GY; Jeong YJ
Radiology; 2023 Feb; 306(2):e221172. PubMed ID: 36219115
[TBL] [Abstract][Full Text] [Related]
11. Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial.
Upperton S; Beirne P; Bhartia B; Boland A; Bradley C; Crosbie PAJ; Darby M; Eckert C; Gabe R; Hancock N; Kennedy MPT; Lindop J; Rogerson S; Shinkins B; Simmonds I; Sutherland TJT; Callister MEJ
BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37612098
[TBL] [Abstract][Full Text] [Related]
12. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
Hunninghake GM; Goldin JG; Kadoch MA; Kropski JA; Rosas IO; Wells AU; Yadav R; Lazarus HM; Abtin FG; Corte TJ; de Andrade JA; Johannson KA; Kolb MR; Lynch DA; Oldham JM; Spagnolo P; Strek ME; Tomassetti S; Washko GR; White ES;
Chest; 2022 Feb; 161(2):470-482. PubMed ID: 34197782
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease.
Hewitt RJ; Bartlett EC; Ganatra R; Butt H; Kouranos V; Chua F; Kokosi M; Molyneaux PL; Desai SR; Wells AU; Jenkins RG; Renzoni EA; Kemp SV; Devaraj A; George PM
Thorax; 2022 Nov; 77(11):1149-1151. PubMed ID: 35940878
[TBL] [Abstract][Full Text] [Related]
14. Suspected Interstitial Lung Disease in COPDGene Study.
Rose JA; Menon AA; Hino T; Hata A; Nishino M; Lynch DA; Rosas IO; El-Chemaly S; Raby BA; Ash SY; Choi B; Washko GR; Silverman EK; Cho MH; Hatabu H; Putman RK; Hunninghake GM
Am J Respir Crit Care Med; 2023 Jan; 207(1):60-68. PubMed ID: 35930450
[No Abstract] [Full Text] [Related]
15. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
Jin GY; Lynch D; Chawla A; Garg K; Tammemagi MC; Sahin H; Misumi S; Kwon KS
Radiology; 2013 Aug; 268(2):563-71. PubMed ID: 23513242
[TBL] [Abstract][Full Text] [Related]
16. An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J).
Ichikado K; Ichiyasu H; Iyonaga K; Kawamura K; Higashi N; Johkoh T; Fujimoto K; Morinaga J; Yoshida M; Mitsuzaki K; Suga M; Tanabe N; Handa T; Hirai T; Sakagami T
BMC Pulm Med; 2023 Jun; 23(1):199. PubMed ID: 37291485
[TBL] [Abstract][Full Text] [Related]
17. Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning-based Texture Analysis.
Chae KJ; Lim S; Seo JB; Hwang HJ; Choi H; Lynch D; Jin GY
Radiology; 2023 May; 307(4):e222828. PubMed ID: 37097142
[TBL] [Abstract][Full Text] [Related]
18. Newly diagnosed non-small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis.
Zhu M; Yi J; Su Y; Zhang Y; Gao Y; Xu X; Zhang S; Zhang Y; Huang K
Thorac Cancer; 2023 Jul; 14(19):1874-1882. PubMed ID: 37232276
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
Hunninghake GM; Quesada-Arias LD; Carmichael NE; Martinez Manzano JM; Poli De Frías S; Baumgartner MA; DiGianni L; Gampala-Sagar SN; Leone DA; Gulati S; El-Chemaly S; Goldberg HJ; Putman RK; Hatabu H; Raby BA; Rosas IO
Am J Respir Crit Care Med; 2020 May; 201(10):1240-1248. PubMed ID: 32011908
[No Abstract] [Full Text] [Related]
20. Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.
Hida T; Hata A; Lu J; Valtchinov VI; Hino T; Nishino M; Honda H; Tomiyama N; Christiani DC; Hatabu H
Cancer Imaging; 2021 Jan; 21(1):14. PubMed ID: 33468255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
